High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$625K
$625,293
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RAPP |
Rapport Therapeutics, Inc.
|
COO
Discretionary Sell
|
2026-03-05 | $58,265 | S | Form 4 |
|
RAPP
M
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
Other
2026-02-19
$10,800
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-19 | $10,800 | M | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $320,373x4 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17
$246,655x3
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-17 | $246,655x3 | S | Form 4 |